Skip to main content

VCPeer

Founder intelligence for smarter fundraising

Product

Browse VCs
All Reviews
Submit Review
Deal Flow
Raise Tracker
Compare VCs
Community
Retrospectives
Deal Room
Find Intros
Investor Updates
Deck Analytics

Tools

All Tools
Find Your VC
Term Sheet Analyzer
Compare VCs
Valuation Calculator
Cap Table Simulator
Term Sheet Benchmarks
Compensation Data
Negotiation Practice
SAFE Calculator
Runway Calculator
Data Room
Benchmarks
Raise Readiness

Resources

Fundraising Guide
Pitch Deck Guide
VC Glossary
Market Reports
Events
API Docs
Support
Open Data
Embed Widgets
API Status
Data Licensing

Community

Sectors
Stages
VC Locations
Weekly Digest
For VCs

Legal

Privacy Policy
Terms of Service
About

© 2026 VCPeer. All rights reserved.

Built by founders, for founders

Home Search Submit Pipeline Profile

AXA Venture Partners (US)/DNA Profile

VC DNA Profile

AXA Venture Partners (US)

Series ASeries BEnterpriseHealthFintech

75

Good

Archetype

The Balanced Player

Response style: Moderately responsive

Best for: Founders raising Series A/Series B in Enterprise or Health

Founder Friendliness65

Founder-Friendly

Watch Out

No major red flags based on current data

Strengths

+Established presence in the market

Weaknesses

-Limited data for deeper analysis

Similar VCs

Valar Ventures (II)

Shared sectors: Enterprise, FintechSame stage focus

Wells Fargo Strategic Capital

Shared sectors: Enterprise, FintechSame stage focus

Valar Ventures

Shared sectors: Enterprise, FintechSame stage focus

Valor Capital Group

Shared sectors: Health, FintechSame stage focus

← Back to AXA Venture Partners (US) profile